BPC-157 treats high blood pressure AND low blood pressure, occasionally in the same rat BPC-157 rescues rats from too much nitric oxide AND too little
In some embodiments, the formulations or composition described herein have a pH and osmolarity as described herein, and have a concentration of active pharmaceutical ingredient between about 0.1-about 70 mg/mL, between about 1 mg-about 70 mg/mL, between about 1 mg-about 50 mg/mL, between about 1 mg/mL and about 20 mg/mL, between about 1 mg/mL to about 10 mg/mL, between about 1 mg/mL to about 5 mg/mL, or between about 0.5 mg/mL to about 5 mg/mL of the active agent by volume of the formulation or composition
Even with perfect aseptic technique, each needle passage through ambient air before entering the vial represents a contamination opportunity
GHK-Cu Benefits Since its discovery, GHK-Cu has demonstrated numerous protective and regenerative benefits, which we summarize below
Lilly hikes revenue forecasts (Q3 tirzepatide US$10.1B) eMarketer / Morgan Stanley, November 2025